BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

331 related articles for article (PubMed ID: 26144017)

  • 1. The role of protein-protein interactions in Toll-like receptor function.
    Berglund NA; Kargas V; Ortiz-Suarez ML; Bond PJ
    Prog Biophys Mol Biol; 2015 Oct; 119(1):72-83. PubMed ID: 26144017
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Structures of the toll-like receptor family and its ligand complexes.
    Jin MS; Lee JO
    Immunity; 2008 Aug; 29(2):182-91. PubMed ID: 18701082
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Caspase-1 targets the TLR adaptor Mal at a crucial TIR-domain interaction site.
    Ulrichts P; Bovijn C; Lievens S; Beyaert R; Tavernier J; Peelman F
    J Cell Sci; 2010 Jan; 123(Pt 2):256-65. PubMed ID: 20048342
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Multiple toll-like receptors (TLRs) display differential bacterial and ligand specificity in the earthworm, Eisenia andrei.
    Park BJ; Yoon YB; Park SC; Shin GS; Kwak HJ; Lee DH; Choi MY; Kim JW; Cho SJ
    J Invertebr Pathol; 2023 Nov; 201():108010. PubMed ID: 37865158
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Structures of TLR-ligand complexes.
    Jin MS; Lee JO
    Curr Opin Immunol; 2008 Aug; 20(4):414-9. PubMed ID: 18585456
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Investigating the effect of key mutations on the conformational dynamics of toll-like receptor dimers through molecular dynamics simulations and protein structure networks.
    Mahita J; Sowdhamini R
    Proteins; 2018 Apr; 86(4):475-490. PubMed ID: 29383743
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Unique features of chicken Toll-like receptors.
    Keestra AM; de Zoete MR; Bouwman LI; Vaezirad MM; van Putten JP
    Dev Comp Immunol; 2013 Nov; 41(3):316-23. PubMed ID: 23628643
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparative sequence analysis of leucine-rich repeats (LRRs) within vertebrate toll-like receptors.
    Matsushima N; Tanaka T; Enkhbayar P; Mikami T; Taga M; Yamada K; Kuroki Y
    BMC Genomics; 2007 May; 8():124. PubMed ID: 17517123
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The structural network of inflammation and cancer: merits and challenges.
    Guven Maiorov E; Keskin O; Gursoy A; Nussinov R
    Semin Cancer Biol; 2013 Aug; 23(4):243-51. PubMed ID: 23712403
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Regulation of innate immune responses by transmembrane interactions: lessons from the TLR family.
    Reuven EM; Fink A; Shai Y
    Biochim Biophys Acta; 2014 Jun; 1838(6):1586-93. PubMed ID: 24480409
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Molecular evolution of vertebrate Toll-like receptors: evolutionary rate difference between their leucine-rich repeats and their TIR domains.
    Mikami T; Miyashita H; Takatsuka S; Kuroki Y; Matsushima N
    Gene; 2012 Jul; 503(2):235-43. PubMed ID: 22587897
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Toll/interleukin-1 receptor (TIR) domain-mediated cellular signaling pathways.
    Narayanan KB; Park HH
    Apoptosis; 2015 Feb; 20(2):196-209. PubMed ID: 25563856
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Molecular analysis of the binding mode of Toll/interleukin-1 receptor (TIR) domain proteins during TLR2 signaling.
    Nada M; Ohnishi H; Tochio H; Kato Z; Kimura T; Kubota K; Yamamoto T; Kamatari YO; Tsutsumi N; Shirakawa M; Kondo N
    Mol Immunol; 2012 Oct; 52(3-4):108-16. PubMed ID: 22673208
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mal (MyD88-adapter-like) is required for Toll-like receptor-4 signal transduction.
    Fitzgerald KA; Palsson-McDermott EM; Bowie AG; Jefferies CA; Mansell AS; Brady G; Brint E; Dunne A; Gray P; Harte MT; McMurray D; Smith DE; Sims JE; Bird TA; O'Neill LA
    Nature; 2001 Sep; 413(6851):78-83. PubMed ID: 11544529
    [TBL] [Abstract][Full Text] [Related]  

  • 15. To con protection: TIR-domain containing proteins (Tcp) and innate immune evasion.
    Patterson NJ; Werling D
    Vet Immunol Immunopathol; 2013 Sep; 155(3):147-54. PubMed ID: 23871438
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inhibition of Toll-like receptors TLR4 and 7 signaling pathways by SIGIRR: a computational approach.
    Gong J; Wei T; Stark RW; Jamitzky F; Heckl WM; Anders HJ; Lech M; Rössle SC
    J Struct Biol; 2010 Mar; 169(3):323-30. PubMed ID: 20025973
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Recognition and signaling by toll-like receptors.
    West AP; Koblansky AA; Ghosh S
    Annu Rev Cell Dev Biol; 2006; 22():409-37. PubMed ID: 16822173
    [TBL] [Abstract][Full Text] [Related]  

  • 18. TollML: a database of toll-like receptor structural motifs.
    Gong J; Wei T; Zhang N; Jamitzky F; Heckl WM; Rössle SC; Stark RW
    J Mol Model; 2010 Jul; 16(7):1283-9. PubMed ID: 20084417
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Expression, purification, and crystallization of Toll/interleukin-1 receptor (TIR) domains.
    Tao X; Tong L
    Methods Mol Biol; 2009; 517():81-8. PubMed ID: 19378015
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Suppression of TLR signaling by targeting TIR domain-containing proteins.
    Fekonja O; Avbelj M; Jerala R
    Curr Protein Pept Sci; 2012 Dec; 13(8):776-88. PubMed ID: 23305364
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.